New York Eye and Ear Infirmary
New York, 10003, United States
NCT Number: NCT01416233
After enucleation or evisceration with placement of a dermis fat graft or integrated orbital implant as a primary procedure, there can be secondary loss of orbital fat volume causing regression of periocular tissue and malpositioning of the cosmetic shell. Current techniques for correction require open surgery to place a sheet/block of biocompatible material or a macroaggregate of fat into the orbit to augment orbital volume for permanent correction. Alternatively, hyaluronic acid-base fillers (Restylane, Radiesse) have been injected, but these have proved to be temporary. The current study seeks to show that a permanent augmentation of orbital volume can be achieved using a closed cannula injection of autologous fat.
Looking for future studies?
Notify Me30 year–80 year
All sexes
Interventional
Not applicable
New York, 10003, United States
To date, 5 subjects have completed fat injections and 4/5 have acquired complete sets of 3 MRIs each. Data analysis has begun. The study has been extended to include 5 more subjects (total 10) to increase the number of data for analysis.
To date, the protocol has been expanded to include 10 subjects of which 6/10 have completed fat injections. The study period has been extended to include MRIs at 2 and 5 years after injection.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
subjects will undergo fat harvesting followed by autologous fat grafting into the orbit into their anophthalmic orbit
Time frame: 1-5 years
Autologous fat will be injected into the orbits of anophthalmic human subjects with secondary loss of orbital volume
Fox, Donald Munro, M.D., P.C.
Indiv
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02465333
Atrophy, Heel Fat Pad Atrophy
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT04769193
Atrophy, Atrophy, Hemifacial
New York, United States
View Trial DetailsNCT05698316
Age Related Macular Degeneration, Atrophy
Nantes, France
View Trial DetailsNCT03495700
Atrophy, Edentulous; Alveolar Process, Atrophy
Leuven, Belgium
View Trial Details